To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
And taxpayers are footing most of the bill.
J&J gets nearly half of its $76 billion in revenue from medications like Tylenol and cancer-fighing drugs.
Good idea or bad idea?
Only 5 out of 100 programs that start at the discovery stage make it to patients.
"This guy has become a household name..."